Journal articles on the topic 'Gut microbiota, vitiligo, melanoma'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Gut microbiota, vitiligo, melanoma.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Mohamed, Asmaa, Jennifer Vella, Mary Jo Turk, and Yina H. Huang. "Dendritic cells instruct differentiation of tissue resident memory T cells in the skin to promote durable tumor immunity." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 57.14. http://dx.doi.org/10.4049/jimmunol.208.supp.57.14.
Full textAkhtar, S., E. Dellacecca, V. Engelhard, K. Knight, and C. Le Poole. "828 Dysbiosis of gut microbiota by ampicillin exacerbates vitiligo." Journal of Investigative Dermatology 137, no. 5 (May 2017): S142. http://dx.doi.org/10.1016/j.jid.2017.02.853.
Full textVujkovic-Cvijin, Ivan, Maria Wei, Nicholas P. Restifo, and Yasmine Belkaid. "Role for skin-associated microbiota in development of endogenous anti-melanocyte immunity in vitiligo." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 58.14. http://dx.doi.org/10.4049/jimmunol.198.supp.58.14.
Full textFrankel, Arthur E., Kenya Honda, Bruce Roberts, Rose Szabady, Amit Reddy, Johnny Lightcap, Steve McClellan, Sachin Kumar Deshmukh, and Andrew Y. Koh. "Precision probiotic therapy enhances immune checkpoint therapy efficacy in melanoma bearing mice." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e14195-e14195. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14195.
Full textPietrzak, Bernadeta, Katarzyna Tomela, Agnieszka Olejnik-Schmidt, Łukasz Galus, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Mackiewicz, and Marcin Schmidt. "A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition." Cancers 14, no. 21 (October 31, 2022): 5369. http://dx.doi.org/10.3390/cancers14215369.
Full textOh, Byeongsang, Frances Boyle, Nick Pavlakis, Stephen Clarke, Thomas Eade, George Hruby, Gillian Lamoury, et al. "The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?" Cancers 13, no. 19 (September 27, 2021): 4824. http://dx.doi.org/10.3390/cancers13194824.
Full textFrankel, Arthur E., Thomas W. Froehlich, Jiwoong Kim, Laura A. Coughlin, Yang Xie, Eugene P. Frenkel, and Andrew Y. Koh. "Metagenomic shotgun sequencing to identify specific human gut microbes associated with immune checkpoint therapy efficacy in melanoma patients." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 9516. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.9516.
Full textYoungster, Ilan, Erez Baruch, Lior Katz, Adi Lahat, Tal Brosh-Nissimov, Jacob Schachter, Omry Koren, Gal Markel, and Ben Boursi. "90. Fecal Microbiota Transplantation in Metastatic Melanoma Patients Resistant to Anti-PD-1 Treatment." Open Forum Infectious Diseases 6, Supplement_2 (October 2019): S7. http://dx.doi.org/10.1093/ofid/ofz359.014.
Full textSpencer, Christine N., Jennifer L. McQuade, Vancheswaran Gopalakrishnan, John A. McCulloch, Marie Vetizou, Alexandria P. Cogdill, Md A. Wadud Khan, et al. "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response." Science 374, no. 6575 (December 24, 2021): 1632–40. http://dx.doi.org/10.1126/science.aaz7015.
Full textGuardamagna, Mora, Miguel-Angel Berciano-Guerrero, Beatriz Villaescusa-González, Elisabeth Perez-Ruiz, Javier Oliver, Rocío Lavado-Valenzuela, Antonio Rueda-Dominguez, Isabel Barragán, and María Isabel Queipo-Ortuño. "Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition." International Journal of Molecular Sciences 23, no. 19 (October 9, 2022): 11990. http://dx.doi.org/10.3390/ijms231911990.
Full textVandoni, G., F. D’Amico, S. Turroni, P. Brigidi, S. Sieri, A. Casirati, G. Borghese, L. Di Guardo, and C. Gavazzi. "Diet and gut microbiota analysis in patients with advanced melanoma undergoing immunotherapy." Clinical Nutrition ESPEN 46 (December 2021): S707. http://dx.doi.org/10.1016/j.clnesp.2021.09.463.
Full textJohnson, Sarah, Golnaz Morad, Nadim Ajami, Jennifer Wargo, Matthew Wong, and Matthew Lastrapes. "838 The role of microbiota in metastatic brain tumors." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A879. http://dx.doi.org/10.1136/jitc-2021-sitc2021.838.
Full textFedorov, D. E., E. I. Olekhnovich, A. V. Pavlenko, K. M. Klimina, I. A. Pokataev, A. I. Manolov, D. N. Konanov, V. A. Veselovsky, and E. N. Ilina. "Intestinal microbiome as a predictor of the anti-PD-1 therapy success: metagenomic data analysis." Biomeditsinskaya Khimiya 66, no. 6 (2020): 502–7. http://dx.doi.org/10.18097/pbmc20206606502.
Full textRossi, Marco, Salvatore M. Aspromonte, Frederick J. Kohlhapp, Jenna H. Newman, Alex Lemenze, Russell J. Pepe, Samuel M. DeFina, et al. "Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine Model." Diagnostics 12, no. 4 (April 12, 2022): 958. http://dx.doi.org/10.3390/diagnostics12040958.
Full textChaput, N., P. Lepage, C. Coutzac, E. Soularue, K. Le Roux, C. Monot, L. Boselli, et al. "Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab." Annals of Oncology 28, no. 6 (June 2017): 1368–79. http://dx.doi.org/10.1093/annonc/mdx108.
Full textChaput, N., P. Lepage, C. Coutzac, E. Soularue, K. Le Roux, C. Monot, L. Boselli, et al. "Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab." Annals of Oncology 30, no. 12 (December 2019): 2012. http://dx.doi.org/10.1093/annonc/mdz224.
Full textTomela, Katarzyna, Bernadeta Pietrzak, Marcin Schmidt, and Andrzej Mackiewicz. "The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients." Life 10, no. 10 (September 25, 2020): 219. http://dx.doi.org/10.3390/life10100219.
Full textChaput, N., P. Lepage, C. Coutzac, E. Soularue, V. Asvatourian, E. Lanoy, C. Mateus, F. Carbonnel, and C. Robert. "Baseline gut microbiota in metastatic melanoma patients treated with ipilimumab: Relation with clinical response and colitis." Annals of Oncology 28 (September 2017): v28—v29. http://dx.doi.org/10.1093/annonc/mdx363.021.
Full textWang, Feng. "Bifidobacterium improves the outcome of immune checkpoint blockade by modulating Treg cell function." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 90.2. http://dx.doi.org/10.4049/jimmunol.204.supp.90.2.
Full textPeng, Zhi, Xiaotian Zhang, Tong Xie, Siyuan Cheng, Zihan Han, Shulin Wang, Zongwen Ban, et al. "Efficacy of fecal microbiota transplantation in patients with anti-PD-1–resistant/refractory gastrointestinal cancers." Journal of Clinical Oncology 41, no. 4_suppl (February 1, 2023): 389. http://dx.doi.org/10.1200/jco.2023.41.4_suppl.389.
Full textFerrucci, Pier Francesco, and Emilia Cocorocchio. "Novel Biomarkers and Druggable Targets in Advanced Melanoma." Cancers 14, no. 1 (December 24, 2021): 81. http://dx.doi.org/10.3390/cancers14010081.
Full textMiller, Wilson H., Bertrand Routy, Rahima Jamal, D. Scott Ernst, Diane Logan, Khashayar Esfahani, Karl Belanger, et al. "Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 9533. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.9533.
Full textLam, Khiem C., April Huang, Romina E. Araya, Quanyi Chen, and Romina S. Goldszmid. "Tumor-intrinsic factors dictate beneficial effect of microbiota-based therapies." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 120.08. http://dx.doi.org/10.4049/jimmunol.208.supp.120.08.
Full textLi, J., L. Xu, Z. Peng, H. Jiang, F. Chao, Y. Ding, J. M. Moll, et al. "841P Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients." Annals of Oncology 33 (September 2022): S934. http://dx.doi.org/10.1016/j.annonc.2022.07.967.
Full textVeziant, Julie, Romain Villéger, Nicolas Barnich, and Mathilde Bonnet. "Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer." Cancers 13, no. 9 (May 5, 2021): 2215. http://dx.doi.org/10.3390/cancers13092215.
Full textWeinberg, Frank, Robert P. Dickson, Deepak Nagrath, and Nithya Ramnath. "The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?" Cancers 13, no. 1 (December 22, 2020): 13. http://dx.doi.org/10.3390/cancers13010013.
Full textTsunoda, Takuya, Kazunori Shimada, Naoki Uchida, Shinichi Kobayashi, and Yasutsuna Sasaki. "Dynamic relationships among tumor, immune response, and microbiota." Trends in Immunotherapy 3, no. 1 (May 4, 2019): 41. http://dx.doi.org/10.24294/ti.v3.i1.79.
Full textRobinson, Matthew, Kevin Vervier, Simon Harris, David Adams, Doreen Milne, Catherine Booth, Emily Barker, et al. "673 Precision microbiome mapping identifies a microbiome signature predictive of Immune checkpoint inhibitor response across multiple research study cohorts." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A711. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0673.
Full textChen, Lili, Xinyu Zhou, Yawei Wang, Dake Wang, Yueshuang Ke, and Xianlu Zeng. "Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice." Molecular Nutrition & Food Research 65, no. 15 (June 18, 2021): 2100096. http://dx.doi.org/10.1002/mnfr.202100096.
Full textDees, Kory, Hyunmin Koo, James Humphreys, Joseph Hakim, David Crossman, Michael Crowley, L. Burt Nabors, Etty Benveniste, Casey Morrow, and Braden McFarland. "IMMU-09. HUMAN MICROBIOTA INFLUENCE THE EFFICACY OF IMMUNOTHERAPY IN A MOUSE MODEL OF GLIOBLASTOMA." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi93—vi94. http://dx.doi.org/10.1093/neuonc/noab196.369.
Full textLee, Pei-Chang, Chi-Jung Wu, Ya-Wen Hung, Chieh-Ju Lee, Yee Chao, Ming-Chih Hou, Yu-Lun Kuo, Shih-Hsuan Chou, and Yi-Hsiang Huang. "Association of gut microbiota and metabolites with tumor response to immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e16165-e16165. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e16165.
Full textZuccaro, Valentina, Andrea Lombardi, Erika Asperges, Paolo Sacchi, Piero Marone, Alessandra Gazzola, Luca Arcaini, and Raffaele Bruno. "The Possible Role of Gut Microbiota and Microbial Translocation Profiling During Chemo-Free Treatment of Lymphoid Malignancies." International Journal of Molecular Sciences 20, no. 7 (April 9, 2019): 1748. http://dx.doi.org/10.3390/ijms20071748.
Full textOey, Oliver, Yu-Yang Liu, Angela Felicia Sunjaya, Daniel Martin Simadibrata, Muhammad Adnan Khattak, and Elin Gray. "Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review." World Journal of Clinical Oncology 13, no. 11 (November 24, 2022): 929–42. http://dx.doi.org/10.5306/wjco.v13.i11.929.
Full textMaleki, Saman, John Lenehan, Jeremy Burton, Michael Silverman, Seema Nair Parvathy, Mikal El-Hajjar, and Mithunah Krishnamoorthy. "P864 Combination of fecal microbiota transplantation from healthy donors with anti-PD1 immunotherapy in treatment-naïve advanced or metastatic melanoma patients." Journal for ImmunoTherapy of Cancer 8, Suppl 1 (April 2020): A11—A12. http://dx.doi.org/10.1136/lba2019.17.
Full textSambi, Manpreet, Leila Bagheri, and Myron R. Szewczuk. "Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates." Journal of Oncology 2019 (February 28, 2019): 1–12. http://dx.doi.org/10.1155/2019/4508794.
Full textRuella, Marco, Mireia Uribe-Herranz, Silvia Beghi, Kalpana Parvathaneni, Nektarios Kostopoulos, Guido Ghilardi, Kimberly Amelsberg, et al. "Gut Microbiota Tuning Promotes Tumor-Associated Antigen Cross Presentation and Enhances CAR T Antitumor Effects." Blood 138, Supplement 1 (November 5, 2021): 163. http://dx.doi.org/10.1182/blood-2021-151093.
Full textWang, Liangliang, Hua Laura Liang, and Ralph Weichselbaum. "Lactobacillus rhamnosus GG re-shapes gut microbiota and triggers STING-type I IFN-dependent antitumor immunity." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 120.04. http://dx.doi.org/10.4049/jimmunol.208.supp.120.04.
Full textLin, Li-Chi, and Yi-Ying Lin. "The Biological Effectiveness and Medical Significance of Far Infrared Radiation (FIR)." Malaysian Journal of Medical and Biological Research 8, no. 1 (June 20, 2021): 41–46. http://dx.doi.org/10.18034/mjmbr.v8i1.564.
Full textPinato, David James, Sarah Howlett, Diego Ottaviani, Heather Urus, Aisha Patel, Takashi Mineo, Cathryn Brock, et al. "Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice." Journal of Clinical Oncology 37, no. 8_suppl (March 10, 2019): 147. http://dx.doi.org/10.1200/jco.2019.37.8_suppl.147.
Full textDiop, Khoudia, Benlaïfaoui Myriam, Wiam Belkaïd, Alexis Nolin-Lapalme, Julie Malo, Marion Tonneau, Ponce Mayra, et al. "Abstract 3524: Role of the gut microbiota in the development of immune-mediated diarrhea and colitis induced by immune checkpoint inhibitors." Cancer Research 82, no. 12_Supplement (June 15, 2022): 3524. http://dx.doi.org/10.1158/1538-7445.am2022-3524.
Full textVanhove, Wiebe, Paul M. Peeters, Isabelle Cleynen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, and Ingrid Arijs. "Review Article. Absent in melanoma 2 (AIM2) in the intestine: diverging actions with converging consequences." Inflammasome 3, no. 1 (January 1, 2017): 1–9. http://dx.doi.org/10.1515/infl-2017-0001.
Full textLeung, Hoi Kit Matthew, Emily Kwun Kwan Lo, and Hani El-Nezami. "Theabrownin Alleviates Colorectal Tumorigenesis in Murine AOM/DSS Model via PI3K/Akt/mTOR Pathway Suppression and Gut Microbiota Modulation." Antioxidants 11, no. 9 (August 30, 2022): 1716. http://dx.doi.org/10.3390/antiox11091716.
Full textFrankel, Arthur E., Laura A. Coughlin, Jiwoong Kim, Thomas W. Froehlich, Yang Xie, Eugene P. Frenkel, and Andrew Y. Koh. "Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients." Neoplasia 19, no. 10 (October 2017): 848–55. http://dx.doi.org/10.1016/j.neo.2017.08.004.
Full textGajewski, Thomas F. "Abstract PL04-03: Germline and microbiome variants impact immunotherapy efficacy through modulation of myeloid cells." Cancer Research 82, no. 12_Supplement (June 15, 2022): PL04–03—PL04–03. http://dx.doi.org/10.1158/1538-7445.am2022-pl04-03.
Full textGaucher, Louis, Leslie Adda, Alice Séjourné, Camille Joachim, Chaby Guillaume, Claire Poulet, Sophie Liabeuf, et al. "Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors." Therapeutic Advances in Medical Oncology 13 (January 2021): 175883592110005. http://dx.doi.org/10.1177/17588359211000591.
Full textElalaoui, Kenza, Claudia Weihe, Andrew Oliver, Brianna Craver, Hew Yeng Lai, Stefan Brooks, Daniel Kim, Jennifer Martiny, Katrine Whiteson, and Angela Fleischman. "Investigating the Role of the Gut Microbiome in the Inflammatory State of Myeloproliferative Neoplasms." Blood 132, Supplement 1 (November 29, 2018): 3051. http://dx.doi.org/10.1182/blood-2018-99-109761.
Full textWang, Yinghong, Weijie Ma, Hamzah Abu-Sbeih, Zhi-Dong Jiang, and Herbert L. DuPont. "Fecal microbiota transplantation (FMT) for immune checkpoint inhibitor induced–colitis (IMC) refractory to immunosuppressive therapy." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 3067. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3067.
Full textFerrari, Valentina, Alessia Melacarne, Francesca Algieri, and Maria Rescigno. "835 Harnessing the microbiota to increase response rates to immunotherapy." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A876. http://dx.doi.org/10.1136/jitc-2021-sitc2021.835.
Full textPorcari, Serena, Chiara Ciccarese, Federica Pinto, Gianluca Quaranta, Silvia De Giorgi, Debora Rondinella, Carlo Romano Settanni, et al. "Fecal microbiota transplantation to improve efficacy of immune checkpoint inhibitors in renal cell carcinoma (TACITO trial)." Journal of Clinical Oncology 40, no. 6_suppl (February 20, 2022): TPS407. http://dx.doi.org/10.1200/jco.2022.40.6_suppl.tps407.
Full textMaia, Manuel C., Valeriy Poroyko, Haejung Won, Lorena Almeida, Paulo Gustavo Bergerot, Nazli Dizman, Joann Hsu, Jeremy Jones, Ravi Salgia, and Sumanta K. Pal. "Association of microbiome and plasma cytokine dynamics to nivolumab response in metastatic renal cell carcinoma (mRCC)." Journal of Clinical Oncology 36, no. 6_suppl (February 20, 2018): 656. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.656.
Full text